Growing community of inventors

San Diego, CA, United States of America

Chun Luo

Average Co-Inventor Count = 1.30

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Chun LuoMark Brian Anderson (1 patent)Chun LuoPing Chen (1 patent)Chun LuoPatrick O'Connor (1 patent)Chun LuoBinh Nguyen (1 patent)Chun LuoKaren Lundgren (1 patent)Chun LuoStephen Margosiak (1 patent)Chun LuoJames Register (1 patent)Chun LuoSmita Gaur (1 patent)Chun LuoJay Sarup (1 patent)Chun LuoYa-Li Deng (1 patent)Chun LuoAnna Tempczyk Russell (1 patent)Chun LuoChen Chen Kan (1 patent)Chun LuoChun Luo (4 patents)Mark Brian AndersonMark Brian Anderson (17 patents)Ping ChenPing Chen (13 patents)Patrick O'ConnorPatrick O'Connor (3 patents)Binh NguyenBinh Nguyen (2 patents)Karen LundgrenKaren Lundgren (1 patent)Stephen MargosiakStephen Margosiak (1 patent)James RegisterJames Register (1 patent)Smita GaurSmita Gaur (1 patent)Jay SarupJay Sarup (1 patent)Ya-Li DengYa-Li Deng (1 patent)Anna Tempczyk RussellAnna Tempczyk Russell (1 patent)Chen Chen KanChen Chen Kan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cg Discovery, Inc. (3 from 3 patents)

2. Agouron Pharmaceuticals, Inc. (1 from 174 patents)


4 patents:

1. 11979133 - Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

2. 11206005 - Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

3. 10291197 - Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

4. 6670167 - Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…